Cargando…

Serum Cystatin C as a Biomarker for Early Diabetic Kidney Disease and Dyslipidemia in Young Type 1 Diabetes Patients

Background and objectives: This study aimed to assess the clinical significance of serum cystatin C in the early diagnosis of renal injury and its association with dyslipidemia in young T1D patients. Materials and Methods: A total of 779 subjects were evaluated for kidney function by estimating glom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stankute, Ingrida, Radzeviciene, Lina, Monstaviciene, Ausra, Dobrovolskiene, Rimante, Danyte, Evalda, Verkauskiene, Rasa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878987/ https://www.ncbi.nlm.nih.gov/pubmed/35208542 http://dx.doi.org/10.3390/medicina58020218

Ejemplares similares

Pancreatic beta‐cell function dynamics in youth with GCK , HNF1A , and KCNJ11 genes mutations during mixed meal tolerance test
por: Stankute, Ingrida, et al.
Publicado: (2022)

Factors Affecting Cardiovascular Risk in Children, Adolescents, and Young Adults with Type 1 Diabetes
por: Stankute, Ingrida, et al.
Publicado: (2019)

The course of diabetes in children, adolescents and young adults: does the autoimmunity status matter?
por: Verkauskiene, Rasa, et al.
Publicado: (2016)

Can coefficient of variation of time-domain analysis be valuable for detecting cardiovascular autonomic neuropathy in young patients with type 1 diabetes: a case control study
por: Razanskaite-Virbickiene, Dovile, et al.
Publicado: (2017)

Co-segregation analysis and functional trial in vivo of candidate genes for monogenic diabetes
por: Stankute, Ingrida, et al.
Publicado: (2022)

HLA-DRB1*03 as a risk factor for microalbuminuria in same duration of type 1 diabetes: a case control study
por: Ražanskaitė-Virbickienė, Dovilė, et al.
Publicado: (2016)

Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
por: Dejenie, Tadesse Asmamaw, et al.
Publicado: (2023)

Telomere Lengths and Serum Proteasome Concentrations in Patients with Type 1 Diabetes and Different Severities of Diabetic Retinopathy in Latvia and Lithuania
por: Svikle, Zane, et al.
Publicado: (2022)

Serum Cystatin C, Markers of Chronic Kidney Disease, and Retinopathy in Persons with Diabetes
por: Wong, Chee Wai, et al.
Publicado: (2015)

Serum Cystatin C Trajectory Is a Marker Associated With Diabetic Kidney Disease
por: Wang, Nana, et al.
Publicado: (2022)

Prevalence of overweight/obesity in relation to dietary habits and lifestyle among 7–17 years old children and adolescents in Lithuania
por: Smetanina, Natalija, et al.
Publicado: (2015)

Serum Cystatin C as a Biomarker for Predicting Coronary Artery Disease in Diabetes
por: Oh, Jee-Young
Publicado: (2010)

Diabetes Dyslipidemia
por: Schofield, Jonathan D., et al.
Publicado: (2016)

The association of plasma cystatin C proteoforms with diabetic chronic kidney disease
por: Yassine, Hussein N., et al.
Publicado: (2016)

Adding Salt to Meals as a Risk Factor of Type 2 Diabetes Mellitus: A Case–Control Study
por: Radzeviciene, Lina, et al.
Publicado: (2017)

Association between Serum Cystatin C and Diabetic Foot Ulceration in Patients with Type 2 Diabetes: A Cross-Sectional Study
por: Zhao, Jie, et al.
Publicado: (2016)

Ubiquitin-proteasome system in diabetic retinopathy
por: Svikle, Zane, et al.
Publicado: (2022)

Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia
por: Kota, Sunil K., et al.
Publicado: (2013)

Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes
por: Krolewski, Andrzej S., et al.
Publicado: (2012)

Diagnostic value of serum cystatin C for diabetic nephropathy: a meta-analysis
por: Liao, Xueling, et al.
Publicado: (2022)

Pathophysiology of Diabetic Dyslipidemia
por: Hirano, Tsutomu
Publicado: (2018)

Colorimetric and Electrochemical Screening for Early Detection of Diabetes Mellitus and Diabetic Retinopathy—Application of Sensor Arrays and Machine Learning
por: Faura, Georgina, et al.
Publicado: (2022)

Serum Cystatin C and Tubular Urinary Enzymes as Biomarkers of Renal Dysfunction in Type 2 Diabetes Mellitus
por: Assal, Heba S., et al.
Publicado: (2013)

Relationship between High Serum Cystatin C Levels and the Risk of Gestational Diabetes Mellitus
por: Zhao, Weijing, et al.
Publicado: (2016)

Association of epicardial adipose tissue with serum level of cystatin C in type 2 diabetes
por: Murai, Tomomi, et al.
Publicado: (2017)

Serum Cystatin C Concentrations in Cats with Hyperthyroidism and Chronic Kidney Disease
por: Williams, T.L., et al.
Publicado: (2016)

Management of diabetic dyslipidemia: An update
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

Role of the Gut in Diabetic Dyslipidemia
por: Stahel, Priska, et al.
Publicado: (2020)

Updates on dyslipidemia in patients with diabetes
por: Ide, Shintaro, et al.
Publicado: (2023)

Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer
por: Gashenko, Elena A., et al.
Publicado: (2013)

Correlation between serum cystatin C level and renal microvascular perfusion assessed by contrast-enhanced ultrasound in patients with diabetic kidney disease
por: Zhao, Ping, et al.
Publicado: (2022)

Spot Urine Albumin to Creatinine Ratio and Serum Cystatin C are Effective for Detection of Diabetic Nephropathy in Childhood Diabetic Patients
por: Chae, Hyun-Wook, et al.
Publicado: (2012)

Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy
por: Royakkers, Annick A. N. M., et al.
Publicado: (2010)

Evaluation of Serum Cystatin C as an Early Biomarker of Acute Kidney Injury in Patients with Acute Pancreatitis
por: Patel, ML, et al.
Publicado: (2020)

Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients
por: Kim, Eun Hee, et al.
Publicado: (2010)

Diagnostic Accuracy of Serum Cystatin C for Early Recognition of Nephropathy in Type 2 Diabetes Mellitus
por: Sapkota, Suman, et al.
Publicado: (2021)

Adequate prescribing of medication does not necessarily translate into good control of diabetes mellitus
por: Norkus, Antanas, et al.
Publicado: (2013)

Serum Cystatin C for Evaluation of Acute Kidney Injury in Adults Treated with Colistin
por: Larki, Rozina Abbasi, et al.
Publicado: (2018)

Cystatin C as an Early Biomarker of Nephropathy in Patients with Type 2 Diabetes
por: Jeon, Yun Kyung, et al.
Publicado: (2011)

Cardiometabolic Health in Adolescents and Young Adults with Congenital Adrenal Hyperplasia
por: Navardauskaite, Ruta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s08bbv6p4etv1eaoc6oc07adqq